Dr Yap on Saruparib in BRCA1/2+, PALB2+, or RAD51C/D+ Advanc

Dr Yap on Saruparib in BRCA1/2+, PALB2+, or RAD51C/D+ Advanced Solid Tumors

Dr Yap on Saruparib in BRCA1/2+, PALB2+, or RAD51C/D+ Advanced Solid Tumors

onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Texas , United States , Timothy Yap , Therapeutics Discovery Division , Department Of Thoracic Head , University Of Texas Md Anderson Cancer Center , Khalifa Institute For Personalized Cancer Therapy , Investigational Cancer Therapeutics , Phasei Program , Neck Medical Oncology , Khalifa Institute , Personalized Cancer Therapy , Cancer Center ,